154 related articles for article (PubMed ID: 35347751)
1. Utility of p63 and PTEN staining in distinguishing cervical microglandular hyperplasia from endometrial endometrioid carcinoma with microglandular/mucinous features.
Aoun BA; Skala SL
Histopathology; 2022 Jun; 80(7):1102-1111. PubMed ID: 35347751
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic application of KRAS mutation testing in uterine microglandular proliferations.
Hong W; Abi-Raad R; Alomari AK; Hui P; Buza N
Hum Pathol; 2015 Jul; 46(7):1000-5. PubMed ID: 25997988
[TBL] [Abstract][Full Text] [Related]
3. Microglandular hyperplasia: a model for the de novo emergence and evolution of endocervical reserve cells.
Witkiewicz AK; Hecht JL; Cviko A; McKeon FD; Ince TA; Crum CP
Hum Pathol; 2005 Feb; 36(2):154-61. PubMed ID: 15754292
[TBL] [Abstract][Full Text] [Related]
4. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
5. PAX2 and cyclin D1 expression in the distinction between cervical microglandular hyperplasia and endometrial microglandular-like carcinoma: a comparison with p16, vimentin, and Ki67.
Stewart CJ; Crook ML
Int J Gynecol Pathol; 2015 Jan; 34(1):90-100. PubMed ID: 25473758
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia.
Cameron RI; Maxwell P; Jenkins D; McCluggage WG
Histopathology; 2002 Oct; 41(4):313-21. PubMed ID: 12383213
[TBL] [Abstract][Full Text] [Related]
7. Mitotically active microglandular hyperplasia of the cervix: a case series with implications for the differential diagnosis.
Abi-Raad R; Alomari A; Hui P; Buza N
Int J Gynecol Pathol; 2014 Sep; 33(5):524-30. PubMed ID: 25083971
[TBL] [Abstract][Full Text] [Related]
8. Microglandular adenocarcinoma of the endometrium: a form of mucinous adenocarcinoma that may be confused with microglandular hyperplasia of the cervix.
Zaloudek C; Hayashi GM; Ryan IP; Powell CB; Miller TR
Int J Gynecol Pathol; 1997 Jan; 16(1):52-9. PubMed ID: 8986533
[TBL] [Abstract][Full Text] [Related]
9. Cervical cytology and immunohistochemical features in endometrial adenocarcinoma simulating microglandular hyperplasia. A case report.
Shidham VB; Dayer AM; Basir Z; Kajdacsy-Balla A
Acta Cytol; 2000; 44(4):661-6. PubMed ID: 10934963
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical differences between mucinous and microglandular adenocarcinomas of the endometrium and benign endocervical epithelium.
Chekmareva M; Ellenson LH; Pirog EC
Int J Gynecol Pathol; 2008 Oct; 27(4):547-54. PubMed ID: 18753965
[TBL] [Abstract][Full Text] [Related]
11. Comparison of morphologic and immunohistochemical features of cervical microglandular hyperplasia with low-grade mucinous adenocarcinoma of the endometrium.
Qiu W; Mittal K
Int J Gynecol Pathol; 2003 Jul; 22(3):261-5. PubMed ID: 12819393
[TBL] [Abstract][Full Text] [Related]
12. How to approach the many faces of endometrioid carcinoma.
Malpica A
Mod Pathol; 2016 Jan; 29 Suppl 1():S29-44. PubMed ID: 26715172
[TBL] [Abstract][Full Text] [Related]
13. Microglandular adenocarcinoma of the uterus mimicking microglandular cervical hyperplasia.
Zamecnik M; Skalova A; Opatrny V
Ann Diagn Pathol; 2003 Jun; 7(3):180-6. PubMed ID: 12808571
[TBL] [Abstract][Full Text] [Related]
14. Mucinous endometrial adenocarcinoma simulating microglandular hyperplasia of the cervix.
Fukunaga M
Pathol Int; 2000 Jul; 50(7):541-5. PubMed ID: 10886736
[TBL] [Abstract][Full Text] [Related]
15. Benign endometrial proliferations mimicking malignancies: a review of problematic entities in small biopsy specimens.
Ip PP
Virchows Arch; 2018 Jun; 472(6):907-917. PubMed ID: 29445890
[TBL] [Abstract][Full Text] [Related]
16. Mucinous epithelial lesions in endometrial curettage material: a diagnostic challenge.
Pavlakis K; Vrekoussis T; Messini I; Voulgaris Z; Chrysanthakis D; Yiannou P; Stofas A; Panoskaltsis T
Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):607-13. PubMed ID: 22531687
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and immunohistochemical characterization of papillary proliferation of the endometrium: A single institutional experience.
Park CK; Yoon G; Cho YA; Kim HS
Oncotarget; 2016 Jun; 7(26):39197-39206. PubMed ID: 27322430
[TBL] [Abstract][Full Text] [Related]
18. Atypical mucinous glandular proliferations in endometrial samplings: follow-up and other clinicopathological findings in 41 cases.
Rawish KR; Desouki MM; Fadare O
Hum Pathol; 2017 May; 63():53-62. PubMed ID: 28232161
[TBL] [Abstract][Full Text] [Related]
19. The expression and diagnostic utility of p63 in the female genital tract.
Houghton O; McCluggage WG
Adv Anat Pathol; 2009 Sep; 16(5):316-21. PubMed ID: 19700941
[TBL] [Abstract][Full Text] [Related]
20. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
